Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy

Bibliographic Details
Main Authors: Toshihiro Shibutani, Risa Goto, Isao Miyazaki, Akihiro Hashimoto, Takamasa Suzuki, Keiji Ishida, Tomonori Haruma, Toshihiro Osada, Takafumi Harada, Hidenori Fujita, Shuichi Ohkubo
Format: Article
Language:English
Published: Nature Portfolio 2024-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-55488-6
_version_ 1827327470286667776
author Toshihiro Shibutani
Risa Goto
Isao Miyazaki
Akihiro Hashimoto
Takamasa Suzuki
Keiji Ishida
Tomonori Haruma
Toshihiro Osada
Takafumi Harada
Hidenori Fujita
Shuichi Ohkubo
author_facet Toshihiro Shibutani
Risa Goto
Isao Miyazaki
Akihiro Hashimoto
Takamasa Suzuki
Keiji Ishida
Tomonori Haruma
Toshihiro Osada
Takafumi Harada
Hidenori Fujita
Shuichi Ohkubo
author_sort Toshihiro Shibutani
collection DOAJ
first_indexed 2024-03-07T15:01:43Z
format Article
id doaj.art-bdcc263dc4a54fd7922cd0afda998ea9
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-03-07T15:01:43Z
publishDate 2024-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-bdcc263dc4a54fd7922cd0afda998ea92024-03-05T19:08:08ZengNature PortfolioScientific Reports2045-23222024-02-011411310.1038/s41598-024-55488-6Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapyToshihiro Shibutani0Risa Goto1Isao Miyazaki2Akihiro Hashimoto3Takamasa Suzuki4Keiji Ishida5Tomonori Haruma6Toshihiro Osada7Takafumi Harada8Hidenori Fujita9Shuichi Ohkubo10Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.Discovery and Preclinical Research Division, Taiho Pharmaceutical Co., Ltd.https://doi.org/10.1038/s41598-024-55488-6
spellingShingle Toshihiro Shibutani
Risa Goto
Isao Miyazaki
Akihiro Hashimoto
Takamasa Suzuki
Keiji Ishida
Tomonori Haruma
Toshihiro Osada
Takafumi Harada
Hidenori Fujita
Shuichi Ohkubo
Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
Scientific Reports
title Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
title_full Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
title_fullStr Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
title_full_unstemmed Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
title_short Author Correction: Modulation of tumor immune microenvironment by TAS-115, a multi-receptor tyrosine kinase inhibitor, promotes antitumor immunity and contributes anti-PD-1 antibody therapy
title_sort author correction modulation of tumor immune microenvironment by tas 115 a multi receptor tyrosine kinase inhibitor promotes antitumor immunity and contributes anti pd 1 antibody therapy
url https://doi.org/10.1038/s41598-024-55488-6
work_keys_str_mv AT toshihiroshibutani authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT risagoto authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT isaomiyazaki authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT akihirohashimoto authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT takamasasuzuki authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT keijiishida authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT tomonoriharuma authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT toshihiroosada authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT takafumiharada authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT hidenorifujita authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy
AT shuichiohkubo authorcorrectionmodulationoftumorimmunemicroenvironmentbytas115amultireceptortyrosinekinaseinhibitorpromotesantitumorimmunityandcontributesantipd1antibodytherapy